extraction technology
Qiagen Sues Zymo Research Over Cell-Free Nucleic Acid Sample Prep IP
Last month, Qiagen filed a patent infringement lawsuit, alleging that Zymo Research infringes its US patents No. 10,184,145 and No. 11,021,736.
The Charlottesville, Virginia-based company expects to add an infectious disease test menu to its system using its proprietary extraction process.
Watchmaker Genomics Raises $40M in Series A Financing
The Boulder, Colorado-based sample preparation firm said it would use the funds for its protein-engineering platform and to grow its operations.
COVID-19 accelerated the growth of several product portfolios, but under CEO Thierry Bernard, the company is ready to put the pandemic behind it — mostly.
Emerging from stealth mode, the Toronto-based firm will use the platform to identify circulating tumor cells and spur drug development in the lung cancer space.